
ANTONAZZO IPPAZIO COSIMO
Publications
Losa, L., Antonazzo, I., Di Martino, G., Mazzaglia, G., Tafuri, S., Mantovani, L., et al. (2024). Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression. VACCINES, 12(5) [10.3390/vaccines12050527]. Detail
Antonazzo, I., Cortesi, P., Zanon, E., Pasca, S., Morfini, M., Santoro, C., et al. (2024). Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients. MEDICINA, 60(1) [10.3390/medicina60010034]. Detail
Mazzaglia, G., Antonazzo, I., Mol, P. (2024). Risk management and drug utilization research. In Drug Utilization Research: Methods and Applications (pp. 428-436). wiley [10.1002/9781119911685.ch42]. Detail
Ponticelli, D., Losa, L., Antonazzo, I., Zampella, A., Di Marino, F., Mottola, G., et al. (2024). Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy. INFECTIOUS DISEASE REPORTS, 16(1), 128-141 [10.3390/idr16010010]. Detail
Brauer, M., Roth, G., Aravkin, A., Zheng, P., Abate, K., Abate, Y., et al. (2024). Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. THE LANCET, 403(10440 (18–24 May 2024)), 2162-2203 [10.1016/s0140-6736(24)00933-4]. Detail